This new platform integrates computational design and directed evolution to develop new antibodies, which are screened for their ability to bind to toxic aggregates that form in diseases like Parkinson's and Alzheimer's.
Designing antivirals for shape-shifting viruses
Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication. However, viruses are…